There isn't one single "most potent" MS drug, as effectiveness varies, but Alemtuzumab (Lemtrada) and Natalizumab (Tysabri) are often ranked at the top for significantly reducing relapses and disability, followed closely by B-cell therapies like Ocrelizumab (Ocrevus), all considered highly effective but come with higher risks, requiring careful consideration with a neurologist to match the drug's power to individual patient needs and disease activity.
New therapies are emerging
Ublituximab-xiiy (Briumvi) was approved by the FDA in 2022. It is used to treat relapsing-remitting and active secondary-progressive forms of MS. Ublituximab-xiiy is given in a vein and stops certain immune system cells from making antibodies that may damage the brain and spinal cord in MS.
Lemtrada® was recently approved by the FDA. It is administered once a year as an IV infusion. This is a powerful medicine for people who have an aggressive form of MS. However, Lemtrada® is associated with a high risk of developing autoimmune diseases that affect thyroid function or blood platelet levels.
When the condition rapidly progresses, it is known as an acute form of the condition called fulminant multiple sclerosis.
In the UK, you can take cladribine (Mavenclad) if you have 'active' or 'very active' relapsing MS and your neurologist thinks a drug like cladribine is a suitable treatment for your type of MS. 'Active' MS means you have relapses, or MRI scans show that you have new or growing lesions.
At the highest level, MS flare-ups are caused by an autoimmune reaction where your body mistakenly attacks your nervous system. However, triggers that may provoke or worsen a multiple sclerosis attack include: Heat. Poor sleep.
Antihistamines, such as diphenhydramine (Benadryl) and cetirizine (Zyrtec), are commonly used to manage allergies. However, these drugs can also make some MS-related symptoms worse.
Tecfidera, the newest pill treatment to enter the market, is also priced in the range of $62,000 per year. “MS DMDs are too expensive,” said Daniel Kantor, M.D., president of the Florida Society of Neurology, founder of the Southern MS Consortium. “This is almost universally recognized.
There are no medications approved by the FDA for the treatment of MS fatigue. The most commonly used off-label symptomatic medications are amantadine and modafinil.
Kesimpta and Ocrevus are both effective for relapsing MS, but Kesimpta may offer advantages in reducing relapse rates and MRI disease activity. Ocrevus remains the only option approved for primary progressive MS.
Lifestyle and home remedies
Fenebrutinib is currently being investigated in two phase 3 trials, with results due in 2025 and 2028. If the results are positive, fenebrutinib will be submitted for regulatory approval.
AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. These illustrations explain how AMPYRA works.
1800 mg of Gabapentin a day is a common dose to help neuropathic pain. The FDA has approved PreGabalin and Cymbalta for treatment of diabetic related peripheral neuropathic pain and fibromyalgia, but we also use these medications for MS neuropathic pain in an off label fashion.
Kesimpta (ofatumumab) Kesimpta (ofatumumab) is a disease modifying drug (DMD) for relapsing remitting MS. You take Kesimpta as an injection under the skin once a month. It reduces the number of relapses by about two thirds (70%).
Kesimpta has an average rating of 7.1 out of 10 from a total of 85 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 16% reported a negative effect. Tysabri has an average rating of 7.7 out of 10 from a total of 98 ratings on Drugs.com.
For those patients who may not have prescription drug coverage, the list price for KESIMPTA is $9,347.07 per treatment.
As well as disability benefits, there's other financial help out there that might make living with MS easier. Find out more about free public transport, disabled facilities grants, help with keeping warm in winter, prescription charges and dealing with debt.
Neuromyelitis optica is often misdiagnosed as multiple sclerosis, also known as MS, or is seen as a type of MS . But NMO is a different condition. Neuromyelitis optica can cause blindness, weakness in the legs or arms, and painful spasms.
Personal Independence Payment (PIP)
You can spend it on whatever you need, such as paying for support to remain independent during relapses, or to help with extra costs such as heating, transport or help around the house. Some people with MS assume they can't get PIP because they're 'not disabled enough'.
Supplements that boost your immune response — for instance, selenium, copper, and manganese — may worsen autoimmune attacks in MS. Large doses of vitamin E and vitamin C can thin your blood, which may lead to MS complications. Single supplements can contain high doses, making them potentially more dangerous.
Multiple sclerosis is a chronic inflammatory disease of the CNS that results from the interplay between heritable and environmental factors. Mounting evidence from different fields of research supports the pivotal role of the Epstein-Barr virus (EBV) in the development of multiple sclerosis.
Based on what we know so far, MS is not an inherited disease. This means that it's not passed down from parents to children. However, the genetic factors that contribute to MS are complex. If you have MS, your children may be more likely to develop MS later in life compared to a child whose parents do not have MS.